AbbVie, AstraZeneca, Boehringer and more face FTC's ire for 'improper' patent listings

7th November 2023 Uncategorised 0

AbbVie, AstraZeneca, Boehringer and more face FTC’s ire for ‘improper’ patent listings
esagonowsky
Tue, 11/07/2023 – 14:06

More: AbbVie, AstraZeneca, Boehringer and more face FTC's ire for 'improper' patent listings
Source: fierce